• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Engelhard Corporation

Engelhard Corporation

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Agilent Technologies to Host Seminars at International Dioxin Symposium in Madrid

    Agilent Technologies to Host Seminars at International Dioxin Symposium in Madrid

  2. Phase 2 COSMOS Study Results Published in The Lancet Demonstrate Efficacy and Safety of Janssen’s Once-Daily Simeprevir in All Oral 12-Week Combination with Sofosbuvir for Genotype 1 Chronic ...

    Phase 2 COSMOS Study Results Published in The Lancet Demonstrate Efficacy and Safety of Janssen’s Once-Daily Simeprevir in All Oral 12-Week Combination with Sofosbuvir for Genotype 1 Chronic Hepatitis C

  3. Employers Must Appeal to the Needs of ‘Savers,’ Not ‘Investors’ to Boost Retirement Readiness, Finds State Street Global Advisors Survey

    Employers Must Appeal to the Needs of ‘Savers,’ Not ‘Investors’ to Boost Retirement Readiness, Finds State Street Global Advisors Survey

  4. Envarsus® Receives European Marketing Authorization for Treatment of Both Kidney and Liver Transplant Patients

    Envarsus® Receives European Marketing Authorization for Treatment of Both Kidney and Liver Transplant Patients

  5. Medivir: Phase II COSMOS Study Results Published in The Lancet on World Hepatitis Day

    Medivir: Phase II COSMOS Study Results Published in The Lancet on World Hepatitis Day

  6. A.M. Best Upgrades Ratings of Al-Sagr National Insurance Company P.S.C.

    A.M. Best Upgrades Ratings of Al-Sagr National Insurance Company P.S.C.

  7. Research and Markets: Clinical Trial Regulatory & Guideline Requirements Seminar: Update on the New Clinical Trial Regulation - 2nd-3rd October 2014, London UK

    Research and Markets: Clinical Trial Regulatory & Guideline Requirements Seminar: Update on the New Clinical Trial Regulation - 2nd-3rd October 2014, London UK

  8. Recovery Gains Momentum, But Persistently Low Inflation Remains a Concern

    This article is for informational purposes only. This article is not intended to provide tax, legal, insurance or other investment advice. Unless otherwise specified, you are solely responsible for determining whether any investment, security or other product or service is appropriate for you based ...

  9. Economic Recovery in the Euro-Zone Area Brightens Outlook

    This article is for informational purposes only. This article is not intended to provide tax, legal, insurance or other investment advice. Unless otherwise specified, you are solely responsible for determining whether any investment, security or other product or service is appropriate for you based ...

1234
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.